STERIS Acquires Cantel Medical Corp.

January 12, 2021

STERIS plc agreed to acquire Cantel Medical Corp. in a cash-and-stock transaction valuing Cantel at approximately $3.6 billion equity ($4.6 billion enterprise), paying $84.66 per Cantel share. The deal expands STERIS’s infection‑prevention and endoscopy capabilities and extends the company into dental customers, with expected pre‑tax cost synergies of ~$110 million by year four and accretion to adjusted EPS in year one.

Buyers
STERIS plc
Targets
Cantel Medical Corp.
Sellers
Cantel common stockholders, Charles M. Diker and affiliated entities (voting support agreement)
Industry
Medical Devices
Location
New Jersey, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.